EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Evidence in the Systemic Treatment of Brain Metastases from Breast Cancer and Future Perspectives on New Drugs, Combinations and Administration Routes: A Narrative Review

Ornella Garrone iD, Fiorella Ruatta, Carmen Giusy Rea, Nerina Denaro iD, Michele Ghidini iD, Carolina Cauchi, Claudia Bareggi, Barbara Galassi, Marco C Merlano iD, Roberto Rosenfeld iD

Cancers · 13.12.2024 · 16 (24) · 4164

DOI: 10.3390/cancers16244164 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 13.12.2024. Verfasst von Ornella Garrone und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health (Ricerca Corrente 2024).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most frequently diagnosed neoplasm all over the world and the second leading cause of cancer death in women. Breast cancer prognosis has significantly improved in the last years due to the advent of novel therapeutic options, both in the early and in advanced stages. However, the spread of the disease to the brain, accounting for 15–30% of the metastatic diagnoses, is challenging, and its poor prognosis represents an unmet medical need, leading to deterioration of quality of life and causing morbidity and mortality. Generally, triple-negative and HER2-positive breast cancer subtypes more frequently spread to the brain or in the leptomeningeal space. Consequently, according to international guidelines, several systemic treatments can be offered as a first option in some subsets of patients. However, a multidisciplinary approach is recommended to offer the most appropriate strategy to patients. Antibody–drug conjugates such as trastuzumab deruxtecan or sacituzumab govitecan along with small molecules have led to important achievements in the treatment of brain metastases from HER2-positive and triple-negative breast cancer. In this narrative review, we will focus on the molecular features leading to the development of brain metastases and explore the risk and the prognostic factors involved in the development of brain metastases. Finally, we will review the major achievements in the treatment landscape of brain metastases from breast cancer and novel medical approaches.

Schlagwörter

Stichwörter der Autor:innen

brain metastasesbreast cancersystemic treatment

Autor:innen und Institutionen

  • Department of Medical Oncology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Scientific Direction, Candiolo Cancer Institute, FPO-IRCCS Candiolo, 10060 Torino, Italy.

ORCID-Profile: Ornella Garrone, Nerina Denaro, Michele Ghidini, Marco C Merlano, Roberto Rosenfeld

Förderung

  • Italian Ministry of Health (Ricerca Corrente 2024)

Zitieren

APA

Garrone, O., Ruatta, F., Rea, C. G., Denaro, N., Ghidini, M., Cauchi, C., Bareggi, C., Galassi, B., Merlano, M. C., & Rosenfeld, R. (2024). Current Evidence in the Systemic Treatment of Brain Metastases from Breast Cancer and Future Perspectives on New Drugs, Combinations and Administration Routes: A Narrative Review. Cancers, 16(24), 4164. https://doi.org/10.3390/cancers16244164

Vancouver

Garrone O, Ruatta F, Rea CG, Denaro N, Ghidini M, Cauchi C, et al. Current Evidence in the Systemic Treatment of Brain Metastases from Breast Cancer and Future Perspectives on New Drugs, Combinations and Administration Routes: A Narrative Review. Cancers. 2024;16(24):4164. doi:10.3390/cancers16244164

BibTeX
@article{Garrone2024,
  author = {Garrone, Ornella and Ruatta, Fiorella and Rea, Carmen Giusy and Denaro, Nerina and Ghidini, Michele and Cauchi, Carolina and Bareggi, Claudia and Galassi, Barbara and Merlano, Marco C and Rosenfeld, Roberto},
  title = {Current Evidence in the Systemic Treatment of Brain Metastases from Breast Cancer and Future Perspectives on New Drugs, Combinations and Administration Routes: A Narrative Review},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {24},
  pages = {4164},
  doi = {10.3390/cancers16244164}
}
Kostenlos starten →